Global Human Single-Cell Multi-Omics Market Research Report 2024

Publication ID:

PB506241942

Publication Date:

June 14, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Human Single-cell multi-omics can analyze genome, epigenome, transcriptome, proteome, and metabolome lineages, unlike live-cell fluorescence imaging, which is a method of destroying cells for analysis.
The global Human Single-Cell Multi-Omics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Single-Cell Multi-Omics in Clinical Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Single-Cell Multi-Omics include 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio and NanoString Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Single-Cell Multi-Omics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Single-Cell Multi-Omics.
Report Scope
The Human Single-Cell Multi-Omics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Single-Cell Multi-Omics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Single-Cell Multi-Omics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
1CellBio
BGI Genomics
Bio-Rad Laboratories
Celsee
Fluidigm Corporation
Fluxion Biosciences
MissionBio
NanoString Technologies
Takara Bio
Segment by Type
Single-Cell Transcriptomics
Single-Cell Genomics
Single-Cell Proteomics
Segment by Application
Clinical Research
Translational Research
Synthetic Biology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Single-Cell Multi-Omics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Single-Cell Multi-Omics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single-Cell Transcriptomics
1.2.3 Single-Cell Genomics
1.2.4 Single-Cell Proteomics
1.3 Market by Application
1.3.1 Global Human Single-Cell Multi-Omics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Research
1.3.3 Translational Research
1.3.4 Synthetic Biology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Single-Cell Multi-Omics Market Perspective (2019-2030)
2.2 Human Single-Cell Multi-Omics Growth Trends by Region
2.2.1 Global Human Single-Cell Multi-Omics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Single-Cell Multi-Omics Historic Market Size by Region (2019-2024)
2.2.3 Human Single-Cell Multi-Omics Forecasted Market Size by Region (2025-2030)
2.3 Human Single-Cell Multi-Omics Market Dynamics
2.3.1 Human Single-Cell Multi-Omics Industry Trends
2.3.2 Human Single-Cell Multi-Omics Market Drivers
2.3.3 Human Single-Cell Multi-Omics Market Challenges
2.3.4 Human Single-Cell Multi-Omics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Single-Cell Multi-Omics Players by Revenue
3.1.1 Global Top Human Single-Cell Multi-Omics Players by Revenue (2019-2024)
3.1.2 Global Human Single-Cell Multi-Omics Revenue Market Share by Players (2019-2024)
3.2 Global Human Single-Cell Multi-Omics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Single-Cell Multi-Omics Revenue
3.4 Global Human Single-Cell Multi-Omics Market Concentration Ratio
3.4.1 Global Human Single-Cell Multi-Omics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Single-Cell Multi-Omics Revenue in 2023
3.5 Human Single-Cell Multi-Omics Key Players Head office and Area Served
3.6 Key Players Human Single-Cell Multi-Omics Product Solution and Service
3.7 Date of Enter into Human Single-Cell Multi-Omics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Single-Cell Multi-Omics Breakdown Data by Type
4.1 Global Human Single-Cell Multi-Omics Historic Market Size by Type (2019-2024)
4.2 Global Human Single-Cell Multi-Omics Forecasted Market Size by Type (2025-2030)
5 Human Single-Cell Multi-Omics Breakdown Data by Application
5.1 Global Human Single-Cell Multi-Omics Historic Market Size by Application (2019-2024)
5.2 Global Human Single-Cell Multi-Omics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Single-Cell Multi-Omics Market Size (2019-2030)
6.2 North America Human Single-Cell Multi-Omics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Single-Cell Multi-Omics Market Size by Country (2019-2024)
6.4 North America Human Single-Cell Multi-Omics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Single-Cell Multi-Omics Market Size (2019-2030)
7.2 Europe Human Single-Cell Multi-Omics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Single-Cell Multi-Omics Market Size by Country (2019-2024)
7.4 Europe Human Single-Cell Multi-Omics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Single-Cell Multi-Omics Market Size (2019-2030)
8.2 Asia-Pacific Human Single-Cell Multi-Omics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Single-Cell Multi-Omics Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Single-Cell Multi-Omics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Single-Cell Multi-Omics Market Size (2019-2030)
9.2 Latin America Human Single-Cell Multi-Omics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Single-Cell Multi-Omics Market Size by Country (2019-2024)
9.4 Latin America Human Single-Cell Multi-Omics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Single-Cell Multi-Omics Market Size (2019-2030)
10.2 Middle East & Africa Human Single-Cell Multi-Omics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Human Single-Cell Multi-Omics Introduction
11.1.4 10x Genomics Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.1.5 10x Genomics Recent Development
11.2 1CellBio
11.2.1 1CellBio Company Detail
11.2.2 1CellBio Business Overview
11.2.3 1CellBio Human Single-Cell Multi-Omics Introduction
11.2.4 1CellBio Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.2.5 1CellBio Recent Development
11.3 BGI Genomics
11.3.1 BGI Genomics Company Detail
11.3.2 BGI Genomics Business Overview
11.3.3 BGI Genomics Human Single-Cell Multi-Omics Introduction
11.3.4 BGI Genomics Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.3.5 BGI Genomics Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Human Single-Cell Multi-Omics Introduction
11.4.4 Bio-Rad Laboratories Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Celsee
11.5.1 Celsee Company Detail
11.5.2 Celsee Business Overview
11.5.3 Celsee Human Single-Cell Multi-Omics Introduction
11.5.4 Celsee Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.5.5 Celsee Recent Development
11.6 Fluidigm Corporation
11.6.1 Fluidigm Corporation Company Detail
11.6.2 Fluidigm Corporation Business Overview
11.6.3 Fluidigm Corporation Human Single-Cell Multi-Omics Introduction
11.6.4 Fluidigm Corporation Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.6.5 Fluidigm Corporation Recent Development
11.7 Fluxion Biosciences
11.7.1 Fluxion Biosciences Company Detail
11.7.2 Fluxion Biosciences Business Overview
11.7.3 Fluxion Biosciences Human Single-Cell Multi-Omics Introduction
11.7.4 Fluxion Biosciences Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.7.5 Fluxion Biosciences Recent Development
11.8 MissionBio
11.8.1 MissionBio Company Detail
11.8.2 MissionBio Business Overview
11.8.3 MissionBio Human Single-Cell Multi-Omics Introduction
11.8.4 MissionBio Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.8.5 MissionBio Recent Development
11.9 NanoString Technologies
11.9.1 NanoString Technologies Company Detail
11.9.2 NanoString Technologies Business Overview
11.9.3 NanoString Technologies Human Single-Cell Multi-Omics Introduction
11.9.4 NanoString Technologies Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.9.5 NanoString Technologies Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Human Single-Cell Multi-Omics Introduction
11.10.4 Takara Bio Revenue in Human Single-Cell Multi-Omics Business (2019-2024)
11.10.5 Takara Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

10x Genomics
1CellBio
BGI Genomics
Bio-Rad Laboratories
Celsee
Fluidigm Corporation
Fluxion Biosciences
MissionBio
NanoString Technologies
Takara Bio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂